Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$0.5 - $1.79 $251,319 - $899,723
-502,639 Reduced 92.5%
40,765 $30,000
Q3 2023

Nov 14, 2023

BUY
$1.44 - $4.76 $782,501 - $2.59 Million
543,404 New
543,404 $934,000
Q3 2022

Nov 14, 2022

SELL
$11.57 - $17.36 $2.98 Million - $4.48 Million
-257,966 Reduced 84.16%
48,544 $621,000
Q2 2022

Aug 15, 2022

SELL
$12.29 - $36.1 $16.7 Million - $49 Million
-1,356,489 Reduced 81.57%
306,510 $3.89 Million
Q1 2022

May 16, 2022

SELL
$27.71 - $41.86 $12.5 Million - $18.9 Million
-452,354 Reduced 21.38%
1,662,999 $57.8 Million
Q4 2021

Feb 14, 2022

BUY
$36.21 - $50.5 $7 Million - $9.76 Million
193,351 Added 10.06%
2,115,353 $89.3 Million
Q3 2021

Nov 15, 2021

BUY
$46.1 - $63.75 $1.41 Million - $1.95 Million
30,622 Added 1.62%
1,922,002 $92.3 Million
Q2 2021

Aug 13, 2021

BUY
$48.42 - $80.6 $6.72 Million - $11.2 Million
138,761 Added 7.92%
1,891,380 $123 Million
Q1 2021

May 17, 2021

SELL
$57.38 - $82.96 $2.49 Million - $3.61 Million
-43,462 Reduced 2.42%
1,752,619 $115 Million
Q4 2020

Feb 16, 2021

BUY
$35.91 - $73.51 $54.1 Million - $111 Million
1,507,848 Added 523.14%
1,796,081 $120 Million
Q3 2020

Nov 16, 2020

BUY
$32.36 - $46.02 $9.33 Million - $13.3 Million
288,233 New
288,233 $12.9 Million
Q2 2020

Aug 13, 2020

SELL
$22.15 - $33.74 $3.95 Million - $6.02 Million
-178,365 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$16.01 - $36.04 $2.86 Million - $6.43 Million
178,365 New
178,365 $4.29 Million
Q4 2018

Feb 14, 2019

SELL
$13.37 - $17.7 $2.57 Million - $3.41 Million
-192,391 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$11.36 - $18.21 $2.19 Million - $3.5 Million
192,391 New
192,391 $3.43 Million

Others Institutions Holding NSTG

About NanoString Technologies Inc


  • Ticker NSTG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 46,494,100
  • Description
  • NanoString Technologies, Inc. develops, manufactures, and sells tools for scientific and clinical research in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCoun...
More about NSTG
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.